James Vollins J.D.
Net Worth

Last updated:

What is James Vollins J.D. net worth?

The estimated net worth of Mr. James Vollins J.D. is at least $4,004,917 as of 4 Feb 2022. He owns shares worth $55,184 as insider, has earned $429,653 from insider trading and has received compensation worth at least $3,520,080 in BioDelivery Sciences International, Inc..

What is the salary of James Vollins J.D.?

Mr. James Vollins J.D. salary is $586,680 per year as Gen. Counsel, Chief Compliance Officer & Corporation Sec. in BioDelivery Sciences International, Inc..

How old is James Vollins J.D.?

Mr. James Vollins J.D. is 56 years old, born in 1969.

What stocks does James Vollins J.D. currently own?

As insider, Mr. James Vollins J.D. owns shares in one company:

Company Title Shares Price per share Total value
BioDelivery Sciences International, Inc. (BDSI) Gen. Counsel, Chief Compliance Officer & Corporation Sec. 9,872 $5.59 $55,184

What does BioDelivery Sciences International, Inc. do?

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc.

BDSI logo
BDSI
BioDelivery Sciences International, Inc.
$5.59

James Vollins J.D. insider trading

BioDelivery Sciences International, Inc.

Mr. James Vollins J.D. has made 8 insider trades between 2019-2022, according to the Form 4 filled with the SEC. Most recently he sold 18,541 units of BDSI stock worth $66,748 on 4 Feb 2022.

The largest trade he's ever made was exercising 29,825 units of BDSI stock on 15 Nov 2019. As of 4 Feb 2022 he still owns at least 9,872 units of BDSI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 18,541 $3.6 $66,748
Option
Restricted Stock Units 28,413 N/A N/A
Option
Common Stock 12,137 N/A N/A
Option
Common Stock 16,276 N/A N/A
Sale
Common Stock 3,833 $4.16 $15,945
Sale
Common Stock 8,303 $3.97 $32,963
Option
Common Stock 3,833 N/A N/A
Option
Restricted Stock Units 3,833 N/A N/A
Option
Restricted Stock Units 8,303 N/A N/A
Option
Common Stock 8,303 N/A N/A
Option
Stock Options (right to buy) 9,505 $4.48 $42,582
Option
Common Stock 9,505 $4.48 $42,582
Sale
Common Stock 9,505 $4.48 $42,582
Option
Common Stock 20,320 $3.46 $70,307
Option
Stock Options (right to buy) 20,320 $3.46 $70,307
Sale
Common Stock 20,320 $3.46 $70,307
Sale
Common Stock 21,666 $3.9 $84,497
Option
Common Stock 21,666 N/A N/A
Option
Stock Options (right to buy) 21,666 $3.9 $84,497
Sale
Common Stock 3,833 $3.5 $13,416
Option
Common Stock 3,833 N/A N/A
Option
Restricted Stock Units 3,833 N/A N/A
Sale
Common Stock 29,825 $3.46 $103,195
Option
Stock Options (right to buy) 29,825 $3.46 $103,195
Option
Common Stock 29,825 $3.46 $103,195

BioDelivery Sciences International key executives

BioDelivery Sciences International, Inc. executives and other stock owners filed with the SEC: